PlexBio Co., Ltd. (TPEX:6572)

PlexBio Statistics

Total Valuation

PlexBio has a market cap or net worth of TWD 805.36 million. The enterprise value is 480.51 million.

Market Cap	805.36M
Enterprise Value	480.51M

Important Dates

The next estimated earnings date is Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

PlexBio has 103.65 million shares outstanding.

Current Share Class	103.65M
Shares Outstanding	103.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.28%
Owned by Institutions (%)	n/a
Float	39.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.26
PB Ratio	2.46
P/TBV Ratio	2.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.45
EV / Sales	3.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.95

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.04.

Current Ratio	2.88
Quick Ratio	2.21
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-296.88

Financial Efficiency

Return on equity (ROE) is -18.12% and return on invested capital (ROIC) is -10.64%.

Return on Equity (ROE)	-18.12%
Return on Assets (ROA)	-6.96%
Return on Invested Capital (ROIC)	-10.64%
Return on Capital Employed (ROCE)	-17.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.27
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.79% in the last 52 weeks. The beta is 0.11, so PlexBio's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-30.79%
50-Day Moving Average	8.61
200-Day Moving Average	9.69
Relative Strength Index (RSI)	44.63
Average Volume (20 Days)	220,988

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PlexBio had revenue of TWD 153.06 million and -64.51 million in losses. Loss per share was -0.62.

Revenue	153.06M
Gross Profit	49.18M
Operating Income	-62.35M
Pretax Income	-64.51M
Net Income	-64.51M
EBITDA	-53.35M
EBIT	-62.35M
Loss Per Share	-0.62

Balance Sheet

The company has 338.58 million in cash and 13.73 million in debt, with a net cash position of 324.85 million or 3.13 per share.

Cash & Cash Equivalents	338.58M
Total Debt	13.73M
Net Cash	324.85M
Net Cash Per Share	3.13
Equity (Book Value)	327.65M
Book Value Per Share	3.16
Working Capital	318.64M

Cash Flow

In the last 12 months, operating cash flow was -160.18 million and capital expenditures -2.91 million, giving a free cash flow of -163.10 million.

Operating Cash Flow	-160.18M
Capital Expenditures	-2.91M
Free Cash Flow	-163.10M
FCF Per Share	-1.57

Margins

Gross margin is 32.13%, with operating and profit margins of -40.73% and -42.15%.

Gross Margin	32.13%
Operating Margin	-40.73%
Pretax Margin	-42.15%
Profit Margin	-42.15%
EBITDA Margin	-34.85%
EBIT Margin	-40.73%
FCF Margin	n/a

Dividends & Yields

PlexBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.01%
FCF Yield	-20.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PlexBio has an Altman Z-Score of 0.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.75
Piotroski F-Score	1